MUMBAI Reliance Industries shares rose Wednesday following reports that the Indian energy company's $14.5 billion offer for bankrupt petrochemicals firm LyondellBasell had been rejected.
Investors had feared Reliance would overpay.
Reliance does not plan to raise its bid, a source familiar with the matter told Reuters on Wednesday. Reliance declined to comment.
The Indian company, controlled by billionaire Mukesh Ambani, has made no secret of its overseas ambitions and has raised a war chest for potential deals by selling $2 billion in stock in recent months.
A person familiar with the matter told Reuters on Tuesday that Luxembourg-headquartered Lyondell had rejected the Reliance offer.
This could mean Reliance, India's largest-listed conglomerate, whose interests include petrochemicals, refining, oil and gas and retail, will look at other overseas options.
It made a $2 billion offer for private Canadian oil-sands firm Value Creation Inc, according to media reports, although three people familiar with Reliance's thinking have said the Calgary, Alberta-based firm may not be an ideal target.
Other possible targets include assets owned by U.S.-based Valero Energy and Sunoco, energy assets belonging to ConocoPhillips, and refineries in Europe that are up for sale, bankers have said.
"While LyondellBasell did offer strategic merit for Reliance, we believe the bid not going through is a better outcome, as it saves Reliance from getting drawn into a bidding war and thus potentially overpaying for the assets," Goldman Sachs analyst Nilesh Banerjee said in a note.
Reliance shares closed up 3.9 percent at 1,021.95 rupees, while the Mumbai market was up 1.4 percent. Reliance shares rose as much as 4.2 percent to 1,024.55 rupees during the trading session.
In November, investors cheered Reliance's Lyondell bid, then valuing the target at about $12 billion, as a potential bargain.
A deal would enhance Reliance's presence in major markets such as the United States and Europe and catapult it into the ranks of top global chemicals makers such as Saudi Arabia's SABIC, Germany's BASF and Dow Chemical Co.
Reliance has since raised its offer twice, sources have said, with chances for success clouded by the prospect that senior creditors such as Apollo Management might take a loss at the price Reliance proposed and could gain more from an independent Lyondell.
At the current offer, Reliance is valuing Lyondell at 10 times 2010 forecast EBITDA. Dow Chemical trades at a multiple of just over eight.
Lyondell adviser Evercore has put a $13.5 billion to $15.5 billion enterprise value range on the company.
Goldman's Banerjee said in his note that it would be better for Reliance to target assets in the exploration and production sector.
A new disclosure statement about Lyondell's proposed plan of reorganization is expected to be filed with the U.S. bankruptcy court in New York "imminently," company spokesman David Harpole said on Wednesday. It had not been filed as of 10:11 a.m. in New York (1511 GMT).
The case is In re: Lyondell Chemical Co, U.S. Bankruptcy Court, Southern District of New York, No. 09-10023.
(Reporting by Pratish Narayanan; Additional reporting by Chelsea Emery in New York; Editing by Ranjit Gangadharan and John Wallace)
Trending On Reuters
The double-digit stock market gains of pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year. Full Article